Form S-4/A - Registration of securities, business combinations: [Amend]

S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Form S-4/A - Registration of securities, business combinations: [Amend]

0001193125-24-228130.txt

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Akari Therapeutics Charts.

Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Akari Therapeutics Charts.

Akari Therapeutics PLC News

Form 8-K - Current report
Tuesday 4 March 2025 (16 hours ago) • Edgar (US Regulatory)

Akari Therapeutics Announces $7.6 Million Private Placement Offering Led by Existing Shareholders and Insiders Priced at the Market Under Nasdaq Rules
Tuesday 4 March 2025 (16 hours ago) • GlobeNewswire Inc.

Akari Therapeutics Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
Thursday 20 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Saturday 15 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Akari Therapeutics Joins Webull Corporate Connect Service Platform
Tuesday 4 February 2025 (4 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 14 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 14 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 14 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 11 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 8 January 2025 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 31 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 31 December 2024 (2 months ago) • Edgar (US Regulatory)

More Akari Therapeutics PLC News Articles

AUD vs US Dollar

Australian SE All Ordina...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions